- Telehealth Visits
- Insurance plan information
Jonathan Lu, MD
Ophthalmic Plastic and Reconstructive Surgery- Telehealth Visits
- Insurance plan information
Jonathan Lu, MD
Ophthalmic Plastic and Reconstructive Surgery- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Ophthalmology, American Board of Ophthalmology
Fellowship
- Oculoplastic Surgery, Massachusetts Eye and Ear Infirmary
Residency
- Ophthalmology, University of Southern California- Los Angeles
Internship
- Transitional, Memorial Sloan Kettering Cancer Center (GME)
Degree
- MD, University of California Davis School of Medicine
My expertise
Locations
My research
Publications
Showing 1-6 of 87 reviews
- February 26, 20265 out of 5 Stars
I have not had a treatment yet . But they are all great
- February 10, 20265 out of 5 Stars
Dr. Lu is very good and always care very deeply about his patient
- February 9, 20265 out of 5 Stars
Dr. Lu I was a very professional surgeon who took care in preforming this procedure!!The doctors at UCSF are the very best!
- January 22, 20264.9 out of 5 Stars
Dr. Lu was very attentive; asked me how I was doing because he noticed my eye and lip twitching. I explained my twitches are prominent if I don't get the injections within the 3month intervals. He was very responsive and suggested I contact him on the portal if that occurs again and he will see if there's an opening available for me to come in. The injection process takes about 5 min or less. I really appreciated this.
- January 20, 20265 out of 5 Stars
Because I left so fast I had to call back to get aftercare details
- January 8, 20265 out of 5 Stars
Dr. Lu is an excellent physician. I feel very lucky to be in his care.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.